Paclitaxel-HDFL for Locally Advanced and Recurrent/Metastatic Gastric Cancers
Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy,response rate,time to treatment
failure,overall survival,toxicities of Paclitaxel-HDFL regimen in locally advanced/inoperable
and recurrent/metastatic gastric cancers. To evaluate the resectability and relapse pattern
after potentially curative resection of neoadjuvant Paclitaxel-HDFL regimen